|
1.
|
Spencer FA, Kroll A, Lessard D, Emery C, Glushchenko AV, Pacifico L, Reed G, Gore JM, Goldberg RJ. Isolated calf deep vein thrombosis in the community setting: the Worcester Venous Thromboembolism study. J Thromb Thrombolysis. 2012 Apr; 33(3):211-7.
|
|
|
|
|
2.
|
McManus DD, Aslam F, Goyal P, Goldberg RJ, Huang W, Gore JM. Incidence, prognosis, and factors associated with cardiac arrest in patients hospitalized with acute coronary syndromes (the Global Registry of Acute Coronary Events Registry). Coron Artery Dis. 2012 Mar; 23(2):105-12.
|
|
|
|
|
3.
|
Vandvik PO, Lincoff AM, Gore JM, Gutterman DD, Sonnenberg FA, Alonso-Coello P, Akl EA, Lansberg MG, Guyatt GH, Spencer FA. Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012 Feb; 141(2 Suppl):e637S-68S.
|
|
|
|
|
4.
|
Miranda AC, Donovan JL, Tran MT, Gore JM. A case of unsuccessful treatment of heparin-induced thrombocytopenia (HIT) with fondaparinux. J Thromb Thrombolysis. 2012 Jan; 33(1):133-5.
|
|
|
|
|
5.
|
Czarnecki A, Welsh RC, Yan RT, Deyoung JP, Gallo R, Rose B, Grondin FR, Kornder JM, Wong GC, Fox KA, Gore JM, Goodman SG, Yan AT. Reperfusion Strategies and Outcomes of ST-Segment Elevation Myocardial Infarction Patients in Canada: Observations From the Global Registry of Acute Coronary Events (GRACE) and the Canadian Registry of Acute Coronary Events (CANRACE). Can J Cardiol. 2012 Jan; 28(1):40-7.
|
|
|
|
|
6.
|
Amad H, Yan AT, Yan RT, Huynh T, Gore JM, Montalescot G, Deyoung JP, Gallo R, Rose B, Steg PG, Goodman SG. The Association Between Prior Use of Aspirin and/or Warfarin and the In-hospital Management and Outcomes in Patients Presenting With Acute Coronary Syndromes: Insights From the Global Registry of Acute Coronary Events (GRACE). Can J Cardiol. 2012 Jan; 28(1):48-53.
|
|
|
|
|
7.
|
Park D, McManus D, Darling C, Goldberg JH, Gore JM, Lessard D, Goldberg RJ. Recent trends in the characteristics and prognosis of patients hospitalized with acute heart failure. Clin Epidemiol. 2011; 3:295-303.
|
|
|
|
|
8.
|
Vuylsteke A, Vincent JL, Payen de La Garanderie D, Anderson FA, Emery L, Wyman A, Rushton-Smith S, Gore JM. Characteristics, practice patterns, and outcomes in patients with acute hypertension: European registry for Studying the Treatment of Acute hyperTension (Euro-STAT). Crit Care. 2011; 15(6):R271.
|
|
|
|
|
9.
|
Gurm HS, Gore JM, Anderson FA, Wyman A, Fox KA, Steg PG, Eagle KA. Comparison of Acute Coronary Syndrome in Patients Receiving Versus Not Receiving Chronic Dialysis (from the Global Registry of Acute Coronary Events [GRACE] Registry). Am J Cardiol. 2012 Jan 1; 109(1):19-25.
|
|
|
|
|
10.
|
Nguyen HL, Saczynski JS, Gore JM, Waring ME, Lessard D, Yarzebski J, Reed G, Spencer FA, Li SX, Goldberg RJ. Long-term Trends in Short-term Outcomes in Acute Myocardial Infarction. Am J Med. 2011 Oct; 124(10):939-46.
|
|
|
|
|
11.
|
Mayer SA, Kurtz P, Wyman A, Sung GY, Multz AS, Varon J, Granger CB, Kleinschmidt K, Lapointe M, Peacock WF, Katz JN, Gore JM, O'Neil B, Anderson FA. Clinical practices, complications, and mortality in neurological patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension registry. Crit Care Med. 2011 Oct; 39(10):2330-6.
|
|
|
|
|
12.
|
Waring ME, Saczynski JS, McManus D, Zacharias M, Lessard D, Gore JM, Goldberg RJ. Weight and Mortality Following Heart Failure Hospitalization among Diabetic Patients. Am J Med. 2011 Sep; 124(9):834-40.
|
|
|
|
|
13.
|
Awad HH, Zubaid M, Alsheikh-Ali AA, Al Suwaidi J, Anderson FA, Gore JM, Goldberg RJ. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events. Am J Cardiol. 2011 Nov 1; 108(9):1252-8.
|
|
|
|
|
14.
|
Krimly A, Yan RT, Yan AT, Deyoung JP, Gallo R, Steg G, Eikelboom J, Gore JM, Fox KA, Fitchett D, Quantz MA, Goodman SG. Use of clopidogrel post-coronary artery bypass surgery in canadian patients with acute coronary syndromes. Can J Cardiol. 2011 Nov; 27(6):711-5.
|
|
|
|
|
15.
|
Wu WC, Waring ME, Lessard D, Yarzebski J, Gore J, Goldberg RJ. Six-month mortality and cardiac catheterization in non-ST-segment elevation myocardial infarction patients with anemia. Coron Artery Dis. 2011 Aug; 22(5):317-23.
|
|
|
|
|
16.
|
McManus DD, Piacentine SM, Lessard D, Gore JM, Yarzebski J, Spencer FA, Goldberg RJ. Thirty-year (1975 to 2005) trends in the incidence rates, clinical features, treatment practices, and short-term outcomes of patients <55 years of age hospitalized with an initial acute myocardial infarction. Am J Cardiol. 2011 Aug 15; 108(4):477-82.
|
|
|
|
|
17.
|
Ali S, Goodman SG, Yan RT, Budaj A, Fox KA, Gore JM, Brieger D, López-Sendón J, Langer A, van de Werf F, Steg PG, Yan AT. Prognostic significance of electrocardiographic-determined left ventricular hypertrophy and associated ST-segment depression in patients with non-ST-elevation acute coronary syndromes. Am Heart J. 2011 May; 161(5):878-85.
|
|
|
|
|
18.
|
Barringhaus KG, Park KL, McManus DD, Steg PG, Montalescot G, Van de Werf F, López-Sendón J, FitzGerald G, Gore JM. Outcomes from patients with Multi-Vessel disease following primary PCI: staged PCI imparts very low mortality. Catheter Cardiovasc Interv. 2011 Apr 1; 77(5):617-22.
|
|
|
|
|
19.
|
McManus DD, Chinali M, Saczynski JS, Gore JM, Yarzebski J, Spencer FA, Lessard D, Goldberg RJ. 30-year trends in heart failure in patients hospitalized with acute myocardial infarction. Am J Cardiol. 2011 Feb 1; 107(3):353-9.
|
|
|
|
|
20.
|
McManus DD, Gore J, Yarzebski J, Spencer F, Lessard D, Goldberg RJ. Recent Trends in the Incidence, Treatment, and Outcomes of Patients with STEMI and NSTEMI. Am J Med. 2011 Jan; 124(1):40-7.
|
|
|
|
|
21.
|
Saczynski JS, Lessard D, Spencer FA, Gurwitz JH, Gore JM, Yarzebski J, Goldberg RJ. Declining length of stay for patients hospitalized with AMI: impact on mortality and readmissions. Am J Med. 2010 Nov; 123(11):1007-15.
|
|
|
|
|
22.
|
Sibbald M, Yan AT, Huang W, Fox KA, Gore JM, Steg PG, Eagle KA, Brieger D, Montalescot G, Goodman SG. Association between smoking, outcomes, and early clopidogrel use in patients with acute coronary syndrome: insights from the Global Registry of Acute Coronary Events. Am Heart J. 2010 Nov; 160(5):855-61.
|
|
|
|
|
23.
|
Nguyen HL, Gore JM, Saczynski JS, Yarzebski J, Reed G, Spencer FA, Goldberg RJ. Age and sex differences and 20-year trends (1986 to 2005) in prehospital delay in patients hospitalized with acute myocardial infarction. Circ Cardiovasc Qual Outcomes. 2010 Nov 1; 3(6):590-8.
|
|
|
|
|
24.
|
Dickey J, Mehta N, Alonso A, Miro S, Gore JM. The Pain That Wouldn't Go Away. Am J Med. 2011 Jan; 124(1):29-31.
|
|
|
|
|
25.
|
Spencer FA, Bates SM, Goldberg RJ, Lessard D, Emery C, Glushchenko A, Gore JM, White RH. A population-based study of inferior vena cava filters in patients with acute venous thromboembolism. Arch Intern Med. 2010 Sep 13; 170(16):1456-62.
|
|
|
|
|
26.
|
Gore JM, Peterson E, Amin A, Anderson FA, Dasta JF, Levy PD, O'Neil BJ, Sung GY, Varon J, Wyman A, Granger CB. Predictors of 90-day readmission among patients with acute severe hypertension. The cross-sectional observational Studying the Treatment of Acute hyperTension (STAT) study. Am Heart J. 2010 Sep; 160(3):521-527.e1.
|
|
|
|
|
27.
|
Nguyen HL, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Gurfinkel EP, Spencer FA, Reed G, Quill A, Anderson FA. Age and sex differences, and changing trends, in the use of evidence-based therapies in acute coronary syndromes: perspectives from a multinational registry. Coron Artery Dis. 2010 Sep; 21(6):336-44.
|
|
|
|
|
28.
|
Santolucito PA, Tighe DA, McManus DD, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Management and outcomes of renal disease and acute myocardial infarction. Am J Med. 2010 Sep; 123(9):847-55.
|
|
|
|
|
29.
|
Shaw PB, Donovan JL, Tran MT, Lemon SC, Burgwinkle P, Gore J. Accuracy assessment of pharmacogenetically predictive warfarin dosing algorithms in patients of an academic medical center anticoagulation clinic. J Thromb Thrombolysis. 2010 Aug; 30(2):220-5.
|
|
|
|
|
30.
|
Spencer FA, Goldberg RJ, Lessard D, Reed G, Emery C, Gore JM, Pacifico L, Weitz JI. Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes. 2010 Jul; 3(4):390-4.
|
|
|
|
|
31.
|
Chew DP, Anderson FA, Avezum A, Eagle KA, FitzGerald G, Gore JM, Dedrick R, Brieger D. Six-month survival benefits associated with clinical guideline recommendations in acute coronary syndromes. Heart. 2010 Aug; 96(15):1201-6.
|
|
|
|
|
32.
|
Goldberg RJ, Spencer FA, Szklo-Coxe M, Tisminetzky M, Yarzebski J, Lessard D, Gore JM, Gaasch W. Symptom presentation in patients hospitalized with acute heart failure. Clin Cardiol. 2010 Jun; 33(6):E73-80.
|
|
|
|
|
33.
|
Fox KA, Eagle KA, Gore JM, Steg PG, Anderson FA. The Global Registry of Acute Coronary Events, 1999 to 2009--GRACE. Heart. 2010 Jul; 96(14):1095-101.
|
|
|
|
|
34.
|
Peacock F, Amin A, Granger CB, Pollack CV, Levy P, Nowak R, Kleinschmidt K, Varon J, Wyman A, Gore JM. Hypertensive heart failure: patient characteristics, treatment, and outcomes. Am J Emerg Med. 2011 Oct; 29(8):855-62.
|
|
|
|
|
35.
|
López-Sendón J, Gurfinkel EP, Lopez de Sa E, Agnelli G, Gore JM, Steg PG, Eagle KA, Cantador JR, Fitzgerald G, Granger CB. Factors related to heart rupture in acute coronary syndromes in the Global Registry of Acute Coronary Events. Eur Heart J. 2010 Jun; 31(12):1449-56.
|
|
|
|
|
36.
|
Spencer FA, Montalescot G, Fox KA, Goodman SG, Granger CB, Goldberg RJ, Oliveira GB, Anderson FA, Eagle KA, Fitzgerald G, Gore JM. Delay to reperfusion in patients with acute myocardial infarction presenting to acute care hospitals: an international perspective. Eur Heart J. 2010 Jun; 31(11):1328-36.
|
|
|
|
|
37.
|
Fornasini M, Yarzebski J, Chiriboga D, Lessard D, Spencer FA, Aurigemma P, Gore JM, Goldberg RJ. Contemporary trends in evidence-based treatment for acute myocardial infarction. Am J Med. 2010 Feb; 123(2):166-72.
|
|
|
|
|
38.
|
Elbarasi E, Goodman SG, Yan RT, Welsh RC, Kornder J, Wong GC, Déry JP, Anderson F, Gore JM, Fox KA, Yan AT. Management patterns of non-ST segment elevation acute coronary syndromes in relation to prior coronary revascularization. Am Heart J. 2010 Jan; 159(1):40-6.
|
|
|
|
|
39.
|
Vedre A, Gurm HS, Froehlich JB, Kline-Rogers E, Montalescot G, Gore JM, Brieger D, Quill AL, Eagle KA. Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009 Dec 15; 104(12):1613-7.
|
|
|
|
|
40.
|
Fox KA, Carruthers K, Steg PG, Avezum A, Granger CB, Montalescot G, Goodman SG, Gore JM, Quill AL, Eagle KA. Has the frequency of bleeding changed over time for patients presenting with an acute coronary syndrome? The global registry of acute coronary events. Eur Heart J. 2010 Mar; 31(6):667-75.
|
|
|
|
|
41.
|
Fitzgibbons TP, Hardy OT, Lessard D, Gore JM, Yarzebski J, Goldberg RJ. Body mass index, treatment practices, and mortality in patients with acute heart failure. Coron Artery Dis. 2009 Dec; 20(8):536-43.
|
|
|
|
|
42.
|
Nguyen HL, Saczynski JS, Gore JM, Goldberg RJ. Age and sex differences in duration of prehospital delay in patients with acute myocardial infarction: a systematic review. Circ Cardiovasc Qual Outcomes. 2010 Jan; 3(1):82-92.
|
|
|
|
|
43.
|
Ambrosio G, Del Pinto M, Tritto I, Agnelli G, Bentivoglio M, Zuchi C, Anderson FA, Gore JM, López-Sendón J, Wyman A, Kennelly BM, Fox KA. Chronic nitrate therapy is associated with different presentation and evolution of acute coronary syndromes: insights from 52,693 patients in the Global Registry of Acute Coronary Events. Eur Heart J. 2010 Feb; 31(4):430-8.
|
|
|
|
|
44.
|
Jedrzkiewicz S, Goodman SG, Yan RT, Welsh RC, Kornder J, DeYoung JP, Wong GC, Rose B, Grondin FR, Gallo R, Huang W, Gore JM, Yan AT. Temporal trends in the use of invasive cardiac procedures for non-ST segment elevation acute coronary syndromes according to initial risk stratification. Can J Cardiol. 2009 Nov; 25(11):e370-6.
|
|
|
|
|
45.
|
Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism. The Worcester VTE study. J Thromb Thrombolysis. 2009 Nov; 28(4):401-9.
|
|
|
|
|
46.
|
Katz JN, Gore JM, Amin A, Anderson FA, Dasta JF, Ferguson JJ, Kleinschmidt K, Mayer SA, Multz AS, Peacock WF, Peterson E, Pollack C, Sung GY, Shorr A, Varon J, Wyman A, Emery LA, Granger CB. Practice patterns, outcomes, and end-organ dysfunction for patients with acute severe hypertension: the Studying the Treatment of Acute hyperTension (STAT) registry. Am Heart J. 2009 Oct; 158(4):599-606.e1.
|
|
|
|
|
47.
|
Herman M, Donovan J, Tran M, McKenna B, Gore JM, Goldberg RJ, Tighe DA. Use of beta-blockers and effects on heart rate and blood pressure post-acute coronary syndromes: are we on target? Am Heart J. 2009 Sep; 158(3):378-85.
|
|
|
|
|
48.
|
Montalescot G, Brieger D, Eagle KA, Anderson FA, FitzGerald G, Lee MS, Steg PG, Avezum A, Goodman SG, Gore JM. Unprotected left main revascularization in patients with acute coronary syndromes. Eur Heart J. 2009 Oct; 30(19):2308-17.
|
|
|
|
|
49.
|
Saczynski JS, Darling CE, Spencer FA, Lessard D, Gore JM, Goldberg RJ. Clinical features, treatment practices, and hospital and long-term outcomes of older patients hospitalized with decompensated heart failure: The Worcester Heart Failure Study. J Am Geriatr Soc. 2009 Sep; 57(9):1587-94.
|
|
|
|
|
50.
|
Ruisi CP, Goldberg RJ, Kennelly BM, Goodman SG, Lopez-Sendon J, Granger CB, Avezum A, Eagle KA, FitzGerald G, Gore JM. Pulmonary artery catheterization in patients with acute coronary syndromes. Am Heart J. 2009 Aug; 158(2):170-6.
|
|
|
|
|
51.
|
Joffe SW, Chalian A, Tighe DA, Aurigemma GP, Yarzebski J, Gore JM, Lessard D, Goldberg RJ. Trends in the use of echocardiography and left ventriculography to assess left ventricular ejection fraction in patients hospitalized with acute myocardial infarction. Am Heart J. 2009 Aug; 158(2):185-92.
|
|
|
|
|
52.
|
Goodman SG, Huang W, Yan AT, Budaj A, Kennelly BM, Gore JM, Fox KA, Goldberg RJ, Anderson FA. The expanded Global Registry of Acute Coronary Events: baseline characteristics, management practices, and hospital outcomes of patients with acute coronary syndromes. Am Heart J. 2009 Aug; 158(2):193-201.e1-5.
|
|
|
|
|
53.
|
Saczynski JS, McManus D, Zhou Z, Spencer F, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Trends in atrial fibrillation complicating acute myocardial infarction. Am J Cardiol. 2009 Jul 15; 104(2):169-74.
|
|
|
|
|
54.
|
Pieper KS, Gore JM, FitzGerald G, Granger CB, Goldberg RJ, Steg G, Eagle KA, Anderson FA, Budaj A, Fox KA. Validity of a risk-prediction tool for hospital mortality: the Global Registry of Acute Coronary Events. Am Heart J. 2009 Jun; 157(6):1097-105.
|
|
|
|
|
55.
|
Yan AT, Steg PG, Fitzgerald G, Feldman LJ, Eagle KA, Gore JM, Anderson FA, López-Sendón J, Gurfinkel EP, Brieger D, Goodman SG. Recurrent ischemia across the spectrum of acute coronary syndromes: prevalence and prognostic significance of (re-)infarction and ST-segment changes in a large contemporary registry. Int J Cardiol. 2010 Nov 5; 145(1):15-20.
|
|
|
|
|
56.
|
Spencer FA, Gore JM, Reed G, Lessard D, Pacifico L, Emery C, Crowther MA, Goldberg RJ. Venous thromboembolism and bleeding in a community setting. The Worcester Venous Thromboembolism Study. Thromb Haemost. 2009 May; 101(5):878-85.
|
|
|
|
|
57.
|
López-Sendón J, Dabbous OH, López de Sá E, Stiles M, Gore JM, Brieger D, van de Werf F, Budaj A, Gurfinkel EP, Fox KA. In-hospital outcomes associated with fibrinolytic and thienopyridine use in patients with ST-segment elevation acute myocardial infarction. The global registry of acute coronary events. Rev Esp Cardiol. 2009 May; 62(5):501-9.
|
|
|
|
|
58.
|
Bagnall AJ, Goodman SG, Fox KA, Yan RT, Gore JM, Cheema AN, Huynh T, Chauret D, Fitchett DH, Langer A, Yan AT. Influence of age on use of cardiac catheterization and associated outcomes in patients with non-ST-elevation acute coronary syndromes. Am J Cardiol. 2009 Jun 1; 103(11):1530-6.
|
|
|
|
|
59.
|
Rao RV, Goodman SG, Yan RT, Spencer FA, Fox KA, DeYoung JP, Rose B, Grondin FR, Gallo R, Gore JM, Yan AT. Temporal trends and patterns of early clopidogrel use across the spectrum of acute coronary syndromes. Am Heart J. 2009 Apr; 157(4):642-50.e1.
|
|
|
|
|
60.
|
Floyd KC, Yarzebski J, Spencer FA, Lessard D, Dalen JE, Alpert JS, Gore JM, Goldberg RJ. A 30-year perspective (1975-2005) into the changing landscape of patients hospitalized with initial acute myocardial infarction: Worcester Heart Attack Study. Circ Cardiovasc Qual Outcomes. 2009 Mar; 2(2):88-95.
|
|
|
|
|
61.
|
Goldberg RJ, Spencer FA, Gore JM, Lessard D, Yarzebski J. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009 Mar 10; 119(9):1211-9.
|
|
|
|
|
62.
|
Steg PG, Fox KA, Eagle KA, Furman M, Van de Werf F, Montalescot G, Goodman SG, Avezum A, Huang W, Gore JM. Mortality following placement of drug-eluting and bare-metal stents for ST-segment elevation acute myocardial infarction in the Global Registry of Acute Coronary Events. Eur Heart J. 2009 Feb; 30(3):321-9.
|
|
|
|
|
63.
|
Goldberg RJ, Spencer FA, Fox KA, Brieger D, Steg PG, Gurfinkel E, Dedrick R, Gore JM. Prehospital Delay in Patients With Acute Coronary Syndromes (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009 Mar 1; 103(5):598-603.
|
|
|
|
|
64.
|
Wasser J, Goldberg RJ, Spencer FA, Yarzebski J, Gore JM. Multidecade-long trends (1986-2005) in the utilization of coronary reperfusion and revascularization treatment strategies in patients hospitalized with acute myocardial infarction: a community-wide perspective. Coron Artery Dis. 2009 Jan; 20(1):71-80.
|
|
|
|
|
65.
|
Gore JM, Spencer FA, Gurfinkel EP, López-Sendón J, Steg PG, Granger CB, FitzGerald G, Agnelli G. Thrombocytopenia in patients with an acute coronary syndrome (from the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2009 Jan 15; 103(2):175-80.
|
|
|
|
|
66.
|
Spencer FA, Gore JM, Lessard D, Emery C, Pacifico L, Reed G, Gurwitz JH, Goldberg RJ. Venous thromboembolism in the elderly. A community-based perspective. Thromb Haemost. 2008 Nov; 100(5):780-8.
|
|
|
|
|
67.
|
Rogers WJ, Frederick PD, Stoehr E, Canto JG, Ornato JP, Gibson CM, Pollack CV, Gore JM, Chandra-Strobos N, Peterson ED, French WJ. Trends in presenting characteristics and hospital mortality among patients with ST elevation and non-ST elevation myocardial infarction in the National Registry of Myocardial Infarction from 1990 to 2006. Am Heart J. 2008 Dec; 156(6):1026-34.
|
|
|
|
|
68.
|
Saczynski JS, Yarzebski J, Lessard D, Spencer FA, Gurwitz JH, Gore JM, Goldberg RJ. Trends in prehospital delay in patients with acute myocardial infarction (from the Worcester Heart Attack Study). Am J Cardiol. 2008 Dec 15; 102(12):1589-94.
|
|
|
|
|
69.
|
Saczynski JS, Spencer FA, Gore JM, Gurwitz JH, Yarzebski J, Lessard D, Goldberg RJ. Twenty-year trends in the incidence of stroke complicating acute myocardial infarction: Worcester Heart Attack Study. Arch Intern Med. 2008 Oct 27; 168(19):2104-10.
|
|
|
|
|
70.
|
Avezum A, Piegas LS, Goldberg RJ, Brieger D, Stiles MK, Paolini R, Huang W, Gore JM. Magnitude and prognosis associated with ventricular arrhythmias in patients hospitalized with acute coronary syndromes (from the GRACE Registry). Am J Cardiol. 2008 Dec 15; 102(12):1577-82.
|
|
|
|
|
71.
|
Gore JM, Fitzpatrick G. Global Registry of Acute Coronary Events Risk Score. Am J Cardiol. 2008 Oct 15; 102(8):1114.
|
|
|
|
|
72.
|
Goldberg RJ, Yarzebski J, Spencer FA, Zevallos JC, Lessard D, Gore JM. Thirty-year trends (1975-2005) in the magnitude, patient characteristics, and hospital outcomes of patients with acute myocardial infarction complicated by ventricular fibrillation. Am J Cardiol. 2008 Dec 15; 102(12):1595-601.
|
|
|
|
|
73.
|
Steg PG, Kerner A, Van de Werf F, López-Sendón J, Gore JM, Fitzgerald G, Feldman LJ, Anderson FA, Avezum A. Impact of in-hospital revascularization on survival in patients with non-ST-elevation acute coronary syndrome and congestive heart failure. Circulation. 2008 Sep 9; 118(11):1163-71.
|
|
|
|
|
74.
|
Fox KA, Anderson FA, Goodman SG, Steg PG, Pieper K, Quill A, Gore JM. Time course of events in acute coronary syndromes: implications for clinical practice from the GRACE registry. Nat Clin Pract Cardiovasc Med. 2008 Sep; 5(9):580-9.
|
|
|
|
|
75.
|
Goldberg RJ, Kramer DG, Yarzebski J, Lessard D, Gore JM. Prehospital transport of patients with acute myocardial infarction: a community-wide perspective. Heart Lung. 2008 Jul-Aug; 37(4):266-74.
|
|
|
|
|
76.
|
Nguyen HL, Lessard D, Spencer FA, Yarzebski J, Zevallos JC, Gore JM, Goldberg RJ. Thirty-year trends (1975-2005) in the magnitude and hospital death rates associated with complete heart block in patients with acute myocardial infarction: a population-based perspective. Am Heart J. 2008 Aug; 156(2):227-33.
|
|
|
|
|
77.
|
Devlin G, Gore JM, Elliott J, Wijesinghe N, Eagle KA, Avezum A, Huang W, Brieger D. Management and 6-month outcomes in elderly and very elderly patients with high-risk non-ST-elevation acute coronary syndromes: The Global Registry of Acute Coronary Events. Eur Heart J. 2008 May; 29(10):1275-82.
|
|
|
|
|
78.
|
Goldberg RJ, Goldberg JH, Pruell S, Yarzebski J, Lessard D, Spencer FA, Gore JM. Delays in seeking medical care in hospitalized patients with decompensated heart failure. Am J Med. 2008 Mar; 121(3):212-8.
|
|
|
|
|
79.
|
Santolucito PA, Tighe DA, Lessard D, Ismailov RM, Gore JM, Yarzebski J, Goldberg RJ. Changing trends in the evaluation of ejection fraction in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J. 2008 Mar; 155(3):485-93.
|
|
|
|
|
80.
|
Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med. 2008 Feb 25; 168(4):425-30.
|
|
|
|
|
81.
|
Yarzebski J, Granillo E, Spencer FA, Lessard D, Gurwitz JH, Gore JM, Goldberg RJ. Changing trends (1986-2003) in the use of lipid lowering medication in patients hospitalized with acute myocardial infarction: a community-based perspective. Int J Cardiol. 2009 Feb 6; 132(1):66-74.
|
|
|
|
|
82.
|
Goldberg RJ, Spencer FA, Okolo J, Lessard D, Yarzebski J, Gore JM. Long-term trends (1986-2003) in the use of coronary reperfusion strategies in patients hospitalized with acute myocardial infarction in central Massachusetts. Int J Cardiol. 2008 Dec 17; 131(1):83-9.
|
|
|
|
|
83.
|
Spencer FA, Moscucci M, Granger CB, Gore JM, Goldberg RJ, Steg PG, Goodman SG, Budaj A, FitzGerald G, Fox KA. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction? Circulation. 2007 Dec 11; 116(24):2793-801.
|
|
|
|
|
84.
|
Goldberg RJ, Spencer FA, Steg PG, Flather M, Montalescot G, Gurfinkel EP, Kennelly BM, Goodman SG, Dedrick R, Gore JM. Increasing use of single and combination medical therapy in patients hospitalized for acute myocardial infarction in the 21st century: a multinational perspective. Arch Intern Med. 2007 Sep 10; 167(16):1766-73.
|
|
|
|
|
85.
|
Reuber M, Gore J, Wolstenhome J, Jonas P, Frankson C, Murray C, Styring L. Examining a community model of epilepsy care for people with learning disabilities. Seizure. 2008 Jan; 17(1):84-91.
|
|
|
|
|
86.
|
Spencer FA, Goldberg RJ, Gore JM, Fox KA, Avezum A, Agnelli G, Kritharides L, Anderson FA, Goodman SG, FitzGerald G, Allegrone J, Brieger D. Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl. Am J Cardiol. 2007 Sep 15; 100(6):913-8.
|
|
|
|
|
87.
|
Nallamothu B, Fox KA, Kennelly BM, Van de Werf F, Gore JM, Steg PG, Granger CB, Dabbous OH, Kline-Rogers E, Eagle KA. Relationship of treatment delays and mortality in patients undergoing fibrinolysis and primary percutaneous coronary intervention. The Global Registry of Acute Coronary Events. Heart. 2007 Dec; 93(12):1552-5.
|
|
|
|
|
88.
|
Dabbous OH, Anderson FA, Gore JM, Eagle KA, Fox KA, Mehta RH, Goldberg RJ, Agnelli G, Steg PG. Outcomes with the use of glycoprotein IIb/IIIa inhibitors in non-ST-segment elevation acute coronary syndromes. Heart. 2008 Feb; 94(2):159-65.
|
|
|
|
|
89.
|
Yan RT, Yan AT, Allegrone J, López-Sendón J, Granger CB, Gore JM, Budaj A, Georgescu AA, Hassan Q, Luchansky J, Van de Werf F, Goodman SG. Differences between local hospital and core laboratory interpretation of the admission electrocardiogram in patients with acute coronary syndromes and their relation to outcome. Am J Cardiol. 2007 Jul 15; 100(2):169-74.
|
|
|
|
|
90.
|
Goldberg RJ, Spencer FA, Okolo J, Lessard D, Yarzebski J, Gore JM. Long-term trends in the use of coronary reperfusion strategies in acute myocardial infarction: a community-wide perspective. J Thromb Thrombolysis. 2007 Jun; 23(3):163-71.
|
|
|
|
|
91.
|
Alexander KP, Newby LK, Cannon CP, Armstrong PW, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007 May 15; 115(19):2549-69.
|
|
|
|
|
92.
|
Alexander KP, Newby LK, Armstrong PW, Cannon CP, Gibler WB, Rich MW, Van de Werf F, White HD, Weaver WD, Naylor MD, Gore JM, Krumholz HM, Ohman EM. Acute coronary care in the elderly, part II: ST-segment-elevation myocardial infarction: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology. Circulation. 2007 May 15; 115(19):2570-89.
|
|
|
|
|
93.
|
Rosendorff C, Black HR, Cannon CP, Gersh BJ, Gore J, Izzo JL, Kaplan NM, O'Connor CM, O'Gara PT, Oparil S. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007 May 29; 115(21):2761-88.
|
|
|
|
|
94.
|
Vaghela C, Robinson N, Gore J, Peace B, Lorenc A. Evaluating healing for cancer in a community setting from the perspective of clients and healers: a pilot study. Complement Ther Clin Pract. 2007 Nov; 13(4):240-9.
|
|
|
|
|
95.
|
Fox KA, Steg PG, Eagle KA, Goodman SG, Anderson FA, Granger CB, Flather MD, Budaj A, Quill A, Gore JM. Decline in rates of death and heart failure in acute coronary syndromes, 1999-2006. JAMA. 2007 May 2; 297(17):1892-900.
|
|
|
|
|
96.
|
Oliveira GB, Avezum A, Anderson FA, Budaj A, Dabbous OH, Goodman SG, Steg PG, Goldberg RJ, Brieger D, Fox KA, Gore JM, Granger CB. Use of proven therapies in non-ST-elevation acute coronary syndromes according to evidence-based risk stratification. Am Heart J. 2007 Apr; 153(4):493-9.
|
|
|
|
|
97.
|
Hahn J, Lessard D, Yarzebski J, Goldberg J, Pruell S, Spencer FA, Gore JM, Goldberg RJ. A community-wide perspective into changing trends in the utilization of diagnostic and interventional procedures in patients hospitalized with acute myocardial infarction. Am Heart J. 2007 Apr; 153(4):594-605.
|
|
|
|
|
98.
|
Goldberg RJ, Kramer DG, Lessard D, Yarzebski J, Gore JM. Serum glucose levels and hospital outcomes in patients with acute myocardial infarction without prior diabetes: a community-wide perspective. Coron Artery Dis. 2007 Mar; 18(2):125-31.
|
|
|
|
|
99.
|
Brieger D, Elsik M, Gore JM, Knobel E, Nussbacher A, Piegas LS, Allegrone J, Anderson FA, Avezum A. Predicting coronary artery bypass graft surgery in acute coronary syndromes. EuroIntervention. 2007 Feb; 2(4):452-8.
|
|
|
|
|
100.
|
Steg PG, López-Sendón J, Lopez de Sa E, Goodman SG, Gore JM, Anderson FA, Himbert D, Allegrone J, Van de Werf F. External validity of clinical trials in acute myocardial infarction. Arch Intern Med. 2007 Jan 8; 167(1):68-73.
|
|
|
|
|
101.
|
Gore JM, Spencer FA, Goldberg RJ, Kennelly BM, Fox KA, Allegrone J, Eagle KA, Anderson FA, Steg PG. Use of heparins in Non-ST-elevation acute coronary syndromes. Am J Med. 2007 Jan; 120(1):63-71.
|
|
|
|
|
102.
|
Spencer FA, Lessard D, Doubeni C, Yarzebski J, Gore JM, Goldberg RJ. Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Am Heart J. 2007 Jan; 153(1):140-6.
|
|
|
|
|
103.
|
Chen JL, Sosnov J, Lessard D, Yarzebski J, Gore J, Goldberg R. Use of do-not-resuscitate orders in patients with kidney disease hospitalized with acute myocardial infarction. Am J Kidney Dis. 2007 Jan; 49(1):83-90.
|
|
|
|
|
104.
|
Gurfinkel EP, Perez de la Hoz R, Brito VM, Duronto E, Dabbous OH, Gore JM, Anderson FA. Invasive vs non-invasive treatment in acute coronary syndromes and prior bypass surgery. Int J Cardiol. 2007 Jun 25; 119(1):65-72.
|
|
|
|
|
105.
|
Doubeni C, Bigelow C, Lessard D, Spencer F, Yarzebski J, Gore J, Gurwitz J, Goldberg R. Trends and outcomes associated with angiotensin-converting enzyme inhibitors. Am J Med. 2006 Jul; 119(7):616.e9-16.
|
|
|
|
|
106.
|
Goldberg RJ, Cui J, Olendzki B, Spencer F, Yarzebski J, Lessard D, Gore J. Excess body weight, clinical profile, management practices, and hospital prognosis in men and women after acute myocardial infarction. Am Heart J. 2006 Jun; 151(6):1297-304.
|
|
|
|
|
107.
|
Sosnov J, Lessard D, Goldberg RJ, Yarzebski J, Gore JM. Differential symptoms of acute myocardial infarction in patients with kidney disease: a community-wide perspective. Am J Kidney Dis. 2006 Mar; 47(3):378-84.
|
|
|
|
|
108.
|
Goodman SG, Steg PG, Eagle KA, Fox KA, López-Sendón J, Montalescot G, Budaj A, Kennelly BM, Gore JM, Allegrone J, Granger CB, Gurfinkel EP. The diagnostic and prognostic impact of the redefinition of acute myocardial infarction: lessons from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2006 Mar; 151(3):654-60.
|
|
|
|
|
109.
|
Goldberg RJ, Glatfelter K, Burbank-Schmidt E, Lessard D, Gore JM. Trends in community mortality due to coronary heart disease. Am Heart J. 2006 Feb; 151(2):501-7.
|
|
|
|
|
110.
|
Botkin NF, Spencer FA, Goldberg RJ, Lessard D, Yarzebski J, Gore JM. Changing trends in the long-term prognosis of patients with acute myocardial infarction: a population-based perspective. Am Heart J. 2006 Jan; 151(1):199-205.
|
|
|
|
|
111.
|
Lim MJ, Eagle KA, Gore JM, Anderson FA, Dabbous OH, Mehta RH, Granger CB, Fox KA, Spencer FA, Goldberg RJ. Treating patients with acute coronary syndromes with aggressive antiplatelet therapy (from the Global Registry of Acute Coronary Events). Am J Cardiol. 2005 Oct 1; 96(7):917-21.
|
|
|
|
|
112.
|
Spencer FA, Frederick PD, Goldberg RJ, Gore JM, Tiefenbrunn AJ. Use of combination evidence-based medical therapy prior to acute myocardial infarction (from the National Registry of Myocardial Infarction-4). Am J Cardiol. 2005 Oct 1; 96(7):922-6.
|
|
|
|
|
113.
|
Spencer FA, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Decade-long changes in the use of combination evidence-based medical therapy at discharge for patients surviving acute myocardial infarction. Am Heart J. 2005 Oct; 150(4):838-44.
|
|
|
|
|
114.
|
Dauerman HL, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Bleeding complications in patients with anemia and acute myocardial infarction. Am J Cardiol. 2005 Nov 15; 96(10):1379-83.
|
|
|
|
|
115.
|
Mohapatra R, Tran M, Gore JM, Spencer FA. A review of the oral direct thrombin inhibitor ximelagatran: not yet the end of the warfarin era... Am Heart J. 2005 Jul; 150(1):19-26.
|
|
|
|
|
116.
|
Budaj A, Flasinska K, Gore JM, Anderson FA, Dabbous OH, Spencer FA, Goldberg RJ, Fox KA. Magnitude of and risk factors for in-hospital and postdischarge stroke in patients with acute coronary syndromes: findings from a Global Registry of Acute Coronary Events. Circulation. 2005 Jun 21; 111(24):3242-7.
|
|
|
|
|
117.
|
Cohen MG, Kelly RV, Kong DF, Menon V, Shah M, Ferreira J, Pieper KS, Criger D, Poggio R, Ohman EM, Gore J, Califf RM, Granger CB. Pulmonary artery catheterization in acute coronary syndromes: insights from the GUSTO IIb and GUSTO III trials. Am J Med. 2005 May; 118(5):482-8.
|
|
|
|
|
118.
|
Lim MJ, Spencer FA, Gore JM, Dabbous OH, Agnelli G, Kline-Rogers EM, Dibenedetto D, Eagle KA, Mehta RH. Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry. Eur Heart J. 2005 Jun; 26(11):1063-9.
|
|
|
|
|
119.
|
Van de Werf F, Gore JM, Avezum A, Gulba DC, Goodman SG, Budaj A, Brieger D, White K, Fox KA, Eagle KA, Kennelly BM. Access to catheterisation facilities in patients admitted with acute coronary syndrome: multinational registry study. BMJ. 2005 Feb 26; 330(7489):441.
|
|
|
|
|
120.
|
Goldberg RJ, Spencer F, Lessard D, Yarzebski J, Lareau C, Gore JM. Occurrence of acute myocardial infarction in Worcester, Massachusetts, before, during, and after the terrorists attacks in New York City and Washington, DC, on 11 September 2001. Am J Cardiol. 2005 Jan 15; 95(2):258-60.
|
|
|
|
|
121.
|
Avezum A, Makdisse M, Spencer F, Gore JM, Fox KA, Montalescot G, Eagle KA, White K, Mehta RH, Knobel E, Collet JP. Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2005 Jan; 149(1):67-73.
|
|
|
|
|
122.
|
Goldberg RJ, Spencer FA, Yarzebski J, Lessard D, Gore JM, Alpert JS, Dalen JE. A 25-year perspective into the changing landscape of patients hospitalized with acute myocardial infarction (the Worcester Heart Attack Study). Am J Cardiol. 2004 Dec 1; 94(11):1373-8.
|
|
|
|
|
123.
|
Spencer FA, Fonarow GC, Frederick PD, Wright RS, Every N, Goldberg RJ, Gore JM, Dong W, Becker RC, French W. Early withdrawal of statin therapy in patients with non-ST-segment elevation myocardial infarction: national registry of myocardial infarction. Arch Intern Med. 2004 Oct 25; 164(19):2162-8.
|
|
|
|
|
124.
|
Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PG, Gowda N, Gore JM. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med. 2004 Jul 12; 164(13):1457-63.
|
|
|
|
|
125.
|
Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. JAMA. 2004 Jun 9; 291(22):2727-33.
|
|
|
|
|
126.
|
Spencer FA, Allegrone J, Goldberg RJ, Gore JM, Fox KA, Granger CB, Mehta RH, Brieger D. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med. 2004 Jun 1; 140(11):857-66.
|
|
|
|
|
127.
|
Spencer FA, Lessard D, Gore JM, Yarzebski J, Goldberg RJ. Declining length of hospital stay for acute myocardial infarction and postdischarge outcomes: a community-wide perspective. Arch Intern Med. 2004 Apr 12; 164(7):733-40.
|
|
|
|
|
128.
|
Jackson EA, Yarzebski JL, Goldberg RJ, Wheeler B, Gurwitz JH, Lessard DM, Bedell SE, Gore JM. Do-not-resuscitate orders in patients hospitalized with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med. 2004 Apr 12; 164(7):776-83.
|
|
|
|
|
129.
|
Yarzebski J, Bujor CF, Lessard D, Gore JM, Goldberg RJ. Recent and temporal trends (1975 to 1999) in the treatment, hospital, and long-term outcomes of Hispanic and non-Hispanic white patients hospitalized with acute myocardial infarction: a population-based perspective. Am Heart J. 2004 Apr; 147(4):690-7.
|
|
|
|
|
130.
|
Kandzari DE, Granger CB, Simoons ML, White HD, Simes J, Mahaffey KW, Gore J, Weaver WD, Longstreth WT, Stebbins A, Lee KL, Califf RM, Topol EJ. Risk factors for intracranial hemorrhage and nonhemorrhagic stroke after fibrinolytic therapy (from the GUSTO-i trial). Am J Cardiol. 2004 Feb 15; 93(4):458-61.
|
|
|
|
|
131.
|
Goldberg RJ, Currie K, White K, Brieger D, Steg PG, Goodman SG, Dabbous O, Fox KA, Gore JM. Six-month outcomes in a multinational registry of patients hospitalized with an acute coronary syndrome (the Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2004 Feb 1; 93(3):288-93.
|
|
|
|
|
132.
|
Mehta RH, Sadiq I, Goldberg RJ, Gore JM, Avezum A, Spencer F, Kline-Rogers E, Allegrone J, Pieper K, Fox KA, Eagle KA. Effectiveness of primary percutaneous coronary intervention compared with that of thrombolytic therapy in elderly patients with acute myocardial infarction. Am Heart J. 2004 Feb; 147(2):253-9.
|
|
|
|
|
133.
|
Furman MI, Gore JM, Anderson FA, Budaj A, Goodman SG, Avezum A, López-Sendón J, Klein W, Mukherjee D, Eagle KA, Dabbous OH, Goldberg RJ. Elevated leukocyte count and adverse hospital events in patients with acute coronary syndromes: findings from the Global Registry of Acute Coronary Events (GRACE). Am Heart J. 2004 Jan; 147(1):42-8.
|
|
|
|
|
134.
|
Montalescot G, Van de Werf F, Gulba DC, Avezum A, Brieger D, Kennelly BM, Mazurek T, Spencer F, White K, Gore JM. Stenting and glycoprotein IIb/IIIa inhibition in patients with acute myocardial infarction undergoing percutaneous coronary intervention: findings from the global registry of acute coronary events (GRACE). Catheter Cardiovasc Interv. 2003 Nov; 60(3):360-7.
|
|
|
|
|
135.
|
Mehta RH, Dabbous OH, Granger CB, Kuznetsova P, Kline-Rogers EM, Anderson FA, Fox KA, Gore JM, Goldberg RJ, Eagle KA. Comparison of outcomes of patients with acute coronary syndromes with and without atrial fibrillation. Am J Cardiol. 2003 Nov 1; 92(9):1031-6.
|
|
|
|
|
136.
|
Crowley A, Menon V, Lessard D, Yarzebski J, Jackson E, Gore JM, Goldberg RJ. Sex differences in survival after acute myocardial infarction in patients with diabetes mellitus (Worcester Heart Attack Study). Am Heart J. 2003 Nov; 146(5):824-31.
|
|
|
|
|
137.
|
Silvet H, Spencer F, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Communitywide trends in the use and outcomes associated with beta-blockers in patients with acute myocardial infarction: the Worcester Heart Attack Study. Arch Intern Med. 2003 Oct 13; 163(18):2175-83.
|
|
|
|
|
138.
|
Santopinto JJ, Fox KA, Goldberg RJ, Budaj A, Piñero G, Avezum A, Gulba D, Esteban J, Gore JM, Johnson J, Gurfinkel EP. Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE). Heart. 2003 Sep; 89(9):1003-8.
|
|
|
|
|
139.
|
Menon V, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Leukocytosis and adverse hospital outcomes after acute myocardial infarction. Am J Cardiol. 2003 Aug 15; 92(4):368-72.
|
|
|
|
|
140.
|
Spencer FA, Gore JM, Yarzebski J, Lessard D, Jackson EA, Goldberg RJ. Trends (1986 to 1999) in the incidence and outcomes of in-hospital stroke complicating acute myocardial infarction (The Worcester Heart Attack Study). Am J Cardiol. 2003 Aug 15; 92(4):383-8.
|
|
|
|
|
141.
|
Fox KA, Goodman SG, Anderson FA, Granger CB, Moscucci M, Flather MD, Spencer F, Budaj A, Dabbous OH, Gore JM. From guidelines to clinical practice: the impact of hospital and geographical characteristics on temporal trends in the management of acute coronary syndromes. The Global Registry of Acute Coronary Events (GRACE). Eur Heart J. 2003 Aug; 24(15):1414-24.
|
|
|
|
|
142.
|
Seth P, Gore J. Treatment of acute myocardial infarction: better, but still not good enough. Arch Intern Med. 2003 Jun 23; 163(12):1392-3.
|
|
|
|
|
143.
|
Harrold LR, Esteban J, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Narrowing gender differences in procedure use for acute myocardial infarction: insights from the Worcester heart attack study. J Gen Intern Med. 2003 Jun; 18(6):423-31.
|
|
|
|
|
144.
|
Spencer FA, Jabbour S, Lessard D, Yarzebski J, Ravid S, Zaleskas V, Hyder M, Gore JM, Goldberg RJ. Two-decade-long trends (1975-1997) in the incidence, hospitalization, and long-term death rates associated with complete heart block complicating acute myocardial infarction: a community-wide perspective. Am Heart J. 2003 Mar; 145(3):500-7.
|
|
|
|
|
145.
|
Harrold LR, Lessard D, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. Age and sex differences in the treatment of patients with initial acute myocardial infarction: a community-wide perspective. Cardiology. 2003; 99(1):39-46.
|
|
|
|
|
146.
|
Spencer FA, Santopinto JJ, Gore JM, Goldberg RJ, Fox KA, Moscucci M, White K, Gurfinkel EP. Impact of aspirin on presentation and hospital outcomes in patients with acute coronary syndromes (The Global Registry of Acute Coronary Events [GRACE]). Am J Cardiol. 2002 Nov 15; 90(10):1056-61.
|
|
|
|
|
147.
|
Dauerman HL, Goldberg RJ, White K, Gore JM, Sadiq I, Gurfinkel E, Budaj A, Lopez de Sa E, Lopez-Sendon J. Revascularization, stenting, and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. Am J Cardiol. 2002 Oct 15; 90(8):838-42.
|
|
|
|
|
148.
|
Steg PG, Goldberg RJ, Gore JM, Fox KA, Eagle KA, Flather MD, Sadiq I, Kasper R, Rushton-Mellor SK, Anderson FA. Baseline characteristics, management practices, and in-hospital outcomes of patients hospitalized with acute coronary syndromes in the Global Registry of Acute Coronary Events (GRACE). Am J Cardiol. 2002 Aug 15; 90(4):358-63.
|
|
|
|
|
149.
|
Jackson EA, Sivasubramian R, Spencer FA, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Changes over time in the use of aspirin in patients hospitalized with acute myocardial infarction (1975 to 1997): a population-based perspective. Am Heart J. 2002 Aug; 144(2):259-68.
|
|
|
|
|
150.
|
Ali O, Sadiq I, Goldberg RJ, Yarzebski J, Lessard D, Gurwitz J, Gore JM. Age-specific differences in the use of thrombolytic therapy and hospital outcomes in patients with acute myocardial infarction: a community-wide perspective. J Thromb Thrombolysis. 2002 Aug; 14(1):5-14.
|
|
|
|
|
151.
|
Spencer FA, Meyer TE, Gore JM, Goldberg RJ. Heterogeneity in the management and outcomes of patients with acute myocardial infarction complicated by heart failure: the National Registry of Myocardial Infarction. Circulation. 2002 Jun 4; 105(22):2605-10.
|
|
|
|
|
152.
|
Dauerman HL, Yarzebski J, Gore JM, Lessard D, Goldberg RJ. Use of the invasive management strategy for patients with non-Q-wave myocardial infarction: an observational database report from the Worcester Heart Attack Study. Am Heart J. 2002 Jun; 143(6):1033-9.
|
|
|
|
|
153.
|
Gurwitz JH, Goldberg RJ, Malmgren JA, Barron HV, Tiefenbrunn AJ, Frederick PD, Gore JM. Hospital transfer of patients with acute myocardial infarction: the effects of age, race, and insurance type. Am J Med. 2002 May; 112(7):528-34.
|
|
|
|
|
154.
|
Yarzebski J, Bujor CF, Goldberg RJ, Spencer F, Lessard D, Gore JM. A community-wide survey of physician practices and attitudes toward cholesterol management in patients with recent acute myocardial infarction. Arch Intern Med. 2002 Apr 8; 162(7):797-804.
|
|
|
|
|
155.
|
Goldberg RJ, Yarzebski J, Lessard D, Wu J, Gore JM. Recent trends in the incidence rates of and death rates from atrial fibrillation complicating initial acute myocardial infarction: a community-wide perspective. Am Heart J. 2002 Mar; 143(3):519-27.
|
|
|
|
|
156.
|
Gibler WB, Armstrong PW, Ohman EM, Weaver WD, Stebbins AL, Gore JM, Newby LK, Califf RM, Topol EJ. Persistence of delays in presentation and treatment for patients with acute myocardial infarction: The GUSTO-I and GUSTO-III experience. Ann Emerg Med. 2002 Feb; 39(2):123-30.
|
|
|
|
|
157.
|
Spencer FA, Salami B, Yarzebski J, Lessard D, Gore JM, Goldberg RJ. Temporal trends and associated factors of inpatient cardiac rehabilitation in patients with acute myocardial infarction: a community-wide perspective. J Cardiopulm Rehabil. 2001 Nov-Dec; 21(6):377-84.
|
|
|
|
|
158.
|
Spencer F, Scleparis G, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Decade-long trends (1986 to 1997) in the medical treatment of patients with acute myocardial infarction: A community-wide perspective. Am Heart J. 2001 Oct; 142(4):594-603.
|
|
|
|
|
159.
|
Spencer FA, Goldberg RJ, Frederick PD, Malmgren J, Becker RC, Gore JM. Age and the utilization of cardiac catheterization following uncomplicated first acute myocardial infarction treated with thrombolytic therapy (The Second National Registry of Myocardial Infarction [NRMI-2]). Am J Cardiol. 2001 Jul 15; 88(2):107-11.
|
|
|
|
|
160.
|
Yarzebski J, Spencer F, Goldberg RJ, Lessard D, Gore JM. Temporal trends (1986-1997) in cholesterol level assessment and management practices in patients with acute myocardial infarction: a population-based perspective. Arch Intern Med. 2001 Jun 25; 161(12):1521-8.
|
|
|
|
|
161.
|
Barron HV, Every NR, Parsons LS, Angeja B, Goldberg RJ, Gore JM, Chou TM. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001 Jun; 141(6):933-9.
|
|
|
|
|
162.
|
Furman MI, Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Twenty-two year (1975 to 1997) trends in the incidence, in-hospital and long-term case fatality rates from initial Q-wave and non-Q-wave myocardial infarction: a multi-hospital, community-wide perspective. J Am Coll Cardiol. 2001 May; 37(6):1571-80.
|
|
|
|
|
163.
|
Dauerman HL, Goldberg RJ, Malinski M, Yarzebski J, Lessard D, Gore JM. Outcomes and early revascularization for patients > or = 65 years of age with cardiogenic shock. Am J Cardiol. 2001 Apr 1; 87(7):844-8.
|
|
|
|
|
164.
|
Angeja BG, Rundle AC, Gurwitz JH, Gore JM, Barron HV. Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction 2. Am J Cardiol. 2001 Mar 1; 87(5):627-30, A9.
|
|
|
|
|
165.
|
Becker RC, Burns M, Every N, Maynard C, Frederick P, Spencer FA, Gore JM, Lambrew C. Early clinical outcomes and routine management of patients with non-ST-segment elevation myocardial infarction: a nationwide perspective. Arch Intern Med. 2001 Feb 26; 161(4):601-7.
|
|
|
|
|
166.
|
Vaccarino V, Krumholz HM, Yarzebski J, Gore JM, Goldberg RJ. Sex differences in 2-year mortality after hospital discharge for myocardial infarction. Ann Intern Med. 2001 Feb 6; 134(3):173-81.
|
|
|
|
|
167.
|
Goldberg RJ, Gore JM, Thompson CA, Gurwitz JH. Recent magnitude of and temporal trends (1994-1997) in the incidence and hospital death rates of cardiogenic shock complicating acute myocardial infarction: the second national registry of myocardial infarction. Am Heart J. 2001 Jan; 141(1):65-72.
|
|
|
|
|
168.
|
Gore JM, Brophy CJ, Greenstone MA. How well do we care for patients with end stage chronic obstructive pulmonary disease (COPD)? A comparison of palliative care and quality of life in COPD and lung cancer. Thorax. 2000 Dec; 55(12):1000-6.
|
|
|
|
|
169.
|
Goldberg RJ, Yarzebski J, Lessard D, Gore JM. Decade-long trends and factors associated with time to hospital presentation in patients with acute myocardial infarction: the Worcester Heart Attack study. Arch Intern Med. 2000 Nov 27; 160(21):3217-23.
|
|
|
|
|
170.
|
Dauerman HL, Goldberg RJ, Yarzebski J, Lessard D, Gore JM. The impact of the stent era on the management strategy for acute myocardial infarction: A population-based perspective. Catheter Cardiovasc Interv. 2000 Nov; 51(3):255-8.
|
|
|
|
|
171.
|
Dauerman HL, Lessard D, Yarzebski J, Furman MI, Gore JM, Goldberg RJ. Ten-year trends in the incidence, treatment, and outcome of Q-wave myocardial infarction. Am J Cardiol. 2000 Oct 1; 86(7):730-5.
|
|
|
|
|
172.
|
Dauerman HL, Goldberg RJ, Gore JM. Treatment options for acute myocardial infarction complicated by cardiogenic shock. Cardiol Rev. 2000 Jul-Aug; 8(4):207-15.
|
|
|
|
|
173.
|
Cannon CP, Gibson CM, Lambrew CT, Shoultz DA, Levy D, French WJ, Gore JM, Weaver WD, Rogers WJ, Tiefenbrunn AJ. Relationship of symptom-onset-to-balloon time and door-to-balloon time with mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA. 2000 Jun 14; 283(22):2941-7.
|
|
|
|
|
174.
|
Thompson CA, Yarzebski J, Goldberg RJ, Lessard D, Gore JM, Dalen JE. Changes over time in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction: perspectives from the Worcester Heart Attack Study. Am Heart J. 2000 Jun; 139(6):1014-21.
|
|
|
|
|
175.
|
Becker RC, Burns M, Gore JM, Lambrew C, French W, Rogers WJ. Early and pre-discharge aspirin administration among patients with acute myocardial infarction: current clinical practice and trends in the United States. J Thromb Thrombolysis. 2000 Apr; 9(3):207-15.
|
|
|
|
|
176.
|
Canto JG, Rogers WJ, French WJ, Gore JM, Chandra NC, Barron HV. Payer status and the utilization of hospital resources in acute myocardial infarction: a report from the National Registry of Myocardial Infarction 2. Arch Intern Med. 2000 Mar 27; 160(6):817-23.
|
|
|
|
|
177.
|
Barron HV, Rundle AC, Gore JM, Gurwitz JH, Penney J. Intracranial hemorrhage rates and effect of immediate beta-blocker use in patients with acute myocardial infarction treated with tissue plasminogen activator. Participants in the National Registry of Myocardial Infarction-2. Am J Cardiol. 2000 Feb 1; 85(3):294-8.
|
|
|
|
|
178.
|
Spencer FA, Meyer TE, Goldberg RJ, Yarzebski J, Hatton M, Lessard D, Gore JM. Twenty year trends (1975-1995) in the incidence, in-hospital and long-term death rates associated with heart failure complicating acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999 Nov 1; 34(5):1378-87.
|
|
|
|
|
179.
|
Goldberg RJ, Gurwitz JH, Gore JM. Duration of, and temporal trends (1994-1997) in, prehospital delay in patients with acute myocardial infarction: the second National Registry of Myocardial Infarction. Arch Intern Med. 1999 Oct 11; 159(18):2141-7.
|
|
|
|
|
180.
|
Mahaffey KW, Granger CB, Sloan MA, Green CL, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Neurosurgical evacuation of intracranial hemorrhage after thrombolytic therapy for acute myocardial infarction: experience from the GUSTO-I trial. Global Utilization of Streptokinase and tissue-plasminogen activator (tPA) for Occluded Coronary Arteries. Am Heart J. 1999 Sep; 138(3 Pt 1):493-9.
|
|
|
|
|
181.
|
Canto JG, Rogers WJ, Zhang Y, Roseman JM, French WJ, Gore JM, Chandra NC. The association between the on-site availability of cardiac procedures and the utilization of those services for acute myocardial infarction by payer group. The National Registry of Myocardial Infarction 2 Investigators. Clin Cardiol. 1999 Aug; 22(8):519-24.
|
|
|
|
|
182.
|
Goldberg RJ, Yarzebski J, Lessard D, Gore JM. A two-decades (1975 to 1995) long experience in the incidence, in-hospital and long-term case-fatality rates of acute myocardial infarction: a community-wide perspective. J Am Coll Cardiol. 1999 May; 33(6):1533-9.
|
|
|
|
|
183.
|
Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999 Apr 15; 340(15):1162-8.
|
|
|
|
|
184.
|
McCormick D, Gurwitz JH, Lessard D, Yarzebski J, Gore JM, Goldberg RJ. Use of aspirin, beta-blockers, and lipid-lowering medications before recurrent acute myocardial infarction: missed opportunities for prevention? Arch Intern Med. 1999 Mar 22; 159(6):561-7.
|
|
|
|
|
185.
|
McCormick D, Gurwitz JH, Savageau J, Yarzebski J, Gore JM, Goldberg RJ. Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance. J Gen Intern Med. 1999 Feb; 14(2):73-81.
|
|
|
|
|
186.
|
Tung CY, Granger CB, Sloan MA, Topol EJ, Knight JD, Weaver WD, Mahaffey KW, White H, Clapp-Channing N, Simoons ML, Gore JM, Califf RM, Mark DB. Effects of stroke on medical resource use and costs in acute myocardial infarction. GUSTO I Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries Study. Circulation. 1999 Jan 26; 99(3):370-6.
|
|
|
|
|
187.
|
Schaefer OP, Gore JM. Aspirin sensitivity: the role for aspirin challenge and desensitization in postmyocardial infarction patients. Cardiology. 1999; 91(1):8-13.
|
|
|
|
|
188.
|
Goldberg RJ, McCormick D, Gurwitz JH, Yarzebski J, Lessard D, Gore JM. Age-related trends in short- and long-term survival after acute myocardial infarction: a 20-year population-based perspective (1975-1995). Am J Cardiol. 1998 Dec 1; 82(11):1311-7.
|
|
|
|
|
189.
|
Gurwitz JH, Gore JM, Goldberg RJ, Barron HV, Breen T, Rundle AC, Sloan MA, French W, Rogers WJ. Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2. Ann Intern Med. 1998 Oct 15; 129(8):597-604.
|
|
|
|
|
190.
|
Sloan MA, Sila CA, Mahaffey KW, Granger CB, Longstreth WT, Koudstaal P, White HD, Gore JM, Simoons ML, Weaver WD, Green CL, Topol EJ, Califf RM. Prediction of 30-day mortality among patients with thrombolysis-related intracranial hemorrhage. Circulation. 1998 Oct 6; 98(14):1376-82.
|
|
|
|
|
191.
|
Goldberg RJ, O'Donnell C, Yarzebski J, Bigelow C, Savageau J, Gore JM. Sex differences in symptom presentation associated with acute myocardial infarction: a population-based perspective. Am Heart J. 1998 Aug; 136(2):189-95.
|
|
|
|
|
192.
|
Goldberg RJ, Mooradd M, Gurwitz JH, Rogers WJ, French WJ, Barron HV, Gore JM. Impact of time to treatment with tissue plasminogen activator on morbidity and mortality following acute myocardial infarction (The second National Registry of Myocardial Infarction). Am J Cardiol. 1998 Aug 1; 82(3):259-64.
|
|
|
|
|
193.
|
Sada MJ, French WJ, Carlisle DM, Chandra NC, Gore JM, Rogers WJ. Influence of payor on use of invasive cardiac procedures and patient outcome after myocardial infarction in the United States. Participants in the National Registry of Myocardial Infarction. J Am Coll Cardiol. 1998 Jun; 31(7):1474-80.
|
|
|
|
|
194.
|
Chandra NC, Ziegelstein RC, Rogers WJ, Tiefenbrunn AJ, Gore JM, French WJ, Rubison M. Observations of the treatment of women in the United States with myocardial infarction: a report from the National Registry of Myocardial Infarction-I. Arch Intern Med. 1998 May 11; 158(9):981-8.
|
|
|
|
|
195.
|
Spencer FA, Goldberg RJ, Becker RC, Gore JM. Seasonal distribution of acute myocardial infarction in the second National Registry of Myocardial Infarction. J Am Coll Cardiol. 1998 May; 31(6):1226-33.
|
|
|
|
|
196.
|
Tiefenbrunn AJ, Chandra NC, French WJ, Gore JM, Rogers WJ. Clinical experience with primary percutaneous transluminal coronary angioplasty compared with alteplase (recombinant tissue-type plasminogen activator) in patients with acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol. 1998 May; 31(6):1240-5.
|
|
|
|
|
197.
|
Becker RC, Burns M, Gore JM, Spencer FA, Ball SP, French W, Lambrew C, Bowlby L, Hilbe J, Rogers WJ. Early assessment and in-hospital management of patients with acute myocardial infarction at increased risk for adverse outcomes: a nationwide perspective of current clinical practice. The National Registry of Myocardial Infarction (NRMI-2) Participants. Am Heart J. 1998 May; 135(5 Pt 1):786-96.
|
|
|
|
|
198.
|
Mahaffey KW, Granger CB, Sloan MA, Thompson TD, Gore JM, Weaver WD, White HD, Simoons ML, Barbash GI, Topol EJ, Califf RM. Risk factors for in-hospital nonhemorrhagic stroke in patients with acute myocardial infarction treated with thrombolysis: results from GUSTO-I. Circulation. 1998 Mar 3; 97(8):757-64.
|
|
|
|
|
199.
|
Gebel JM, Sila CA, Sloan MA, Granger CB, Mahaffey KW, Weisenberger J, Green CL, White HD, Gore JM, Weaver WD, Califf RM, Topol EJ. Thrombolysis-related intracranial hemorrhage: a radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. Stroke. 1998 Mar; 29(3):563-9.
|
|
|
|
|
200.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1997 Jun 18; 277(23):1845-6.
|
|
|
|
|
201.
|
Berkowitz SD, Granger CB, Pieper KS, Lee KL, Gore JM, Simoons M, Armstrong PW, Topol EJ, Califf RM. Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators. Circulation. 1997 Jun 3; 95(11):2508-16.
|
|
|
|
|
202.
|
Sloan MA, Price TR, Terrin ML, Forman S, Gore JM, Chaitman BR, Hodges M, Mueller H, Rogers WJ, Knatterud GL, Braunwald E. Ischemic cerebral infarction after rt-PA and heparin therapy for acute myocardial infarction. The TIMI-II pilot and randomized clinical trial combined experience. Stroke. 1997 Jun; 28(6):1107-14.
|
|
|
|
|
203.
|
Goldberg RJ, Ockene IS, Yarzebski J, Savageau J, Gore JM. Use of lipid-lowering medication in patients with acute myocardial infarction (Worcester Heart Attack Study). Am J Cardiol. 1997 Apr 15; 79(8):1095-7.
|
|
|
|
|
204.
|
Chandra H, Yarzebski J, Goldberg RJ, Savageau J, Singleton C, Gurwitz JH, Gore JM. Age-related trends (1986-1993) in the use of thrombolytic agents in patients with acute myocardial infarction. The Worcester Heart Attack Study. Arch Intern Med. 1997 Apr 14; 157(7):741-6.
|
|
|
|
|
205.
|
Kreindel S, Rosetti R, Goldberg R, Savageau J, Yarzebski J, Gore J, Russo A, Bigelow C. Health insurance coverage and outcome following acute myocardial infarction. A community-wide perspective. Arch Intern Med. 1997 Apr 14; 157(7):758-62.
|
|
|
|
|
206.
|
Bovill EG, Tracy RP, Knatterud GL, Stone PH, Nasmith J, Gore JM, Thompson BW, Tofler GH, Kleiman NS, Cannon C, Braunwald E. Hemorrhagic events during therapy with recombinant tissue plasminogen activator, heparin, and aspirin for unstable angina (Thrombolysis in Myocardial Ischemia, phase IIIB trial). Am J Cardiol. 1997 Feb 15; 79(4):391-6.
|
|
|
|
|
207.
|
White HD, Barbash GI, Califf RM, Simes RJ, Granger CB, Weaver WD, Kleiman NS, Aylward PE, Gore JM, Vahanian A, Lee KL, Ross AM, Topol EJ. Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial. Circulation. 1996 Oct 15; 94(8):1826-33.
|
|
|
|
|
208.
|
Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol. 1996 Oct 15; 78(8):945-8.
|
|
|
|
|
209.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1996 Jun 19; 275(23):1797-8.
|
|
|
|
|
210.
|
Becker RC, Gore JM, Lambrew C, Weaver WD, Rubison RM, French WJ, Tiefenbrunn AJ, Bowlby LJ, Rogers WJ. A composite view of cardiac rupture in the United States National Registry of Myocardial Infarction. J Am Coll Cardiol. 1996 May; 27(6):1321-6.
|
|
|
|
|
211.
|
Newby LK, Califf RM, Guerci A, Weaver WD, Col J, Horgan JH, Mark DB, Stebbins A, Van de Werf F, Gore JM, Topol EJ. Early discharge in the thrombolytic era: an analysis of criteria for uncomplicated infarction from the Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries (GUSTO) trial. J Am Coll Cardiol. 1996 Mar 1; 27(3):625-32.
|
|
|
|
|
212.
|
Gurwitz JH, Gore JM, Goldberg RJ, Rubison M, Chandra N, Rogers WJ. Recent age-related trends in the use of thrombolytic therapy in patients who have had acute myocardial infarction. National Registry of Myocardial Infarction. Ann Intern Med. 1996 Feb 1; 124(3):283-91.
|
|
|
|
|
213.
|
Col NF, McLaughlin TJ, Soumerai SB, Hosmer DW, Yarzebski J, Gurwitz JH, Gore JM, Goldberg RJ. The impact of clinical trials on the use of medications for acute myocardial infarction. Results of a community-based study. Arch Intern Med. 1996 Jan 8; 156(1):54-60.
|
|
|
|
|
214.
|
Yarzebski J, Col N, Pagley P, Savageau J, Gore J, Goldberg R. Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 1996 Jan; 131(1):43-50.
|
|
|
|
|
215.
|
Gore JM, Granger CB, Simoons ML, Sloan MA, Weaver WD, White HD, Barbash GI, Van de Werf F, Aylward PE, Topol EJ, et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. Circulation. 1995 Nov 15; 92(10):2811-8.
|
|
|
|
|
216.
|
Levine MN, Goldhaber SZ, Gore JM, Hirsh J, Califf RM. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest. 1995 Oct; 108(4 Suppl):291S-301S.
|
|
|
|
|
217.
|
Cairns JA, Fuster V, Gore J, Kennedy JW. Coronary thrombolysis. Chest. 1995 Oct; 108(4 Suppl):401S-423S.
|
|
|
|
|
218.
|
Pilote L, Califf RM, Sapp S, Miller DP, Mark DB, Weaver WD, Gore JM, Armstrong PW, Ohman EM, Topol EJ. Regional variation across the United States in the management of acute myocardial infarction. GUSTO-1 Investigators. Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries. N Engl J Med. 1995 Aug 31; 333(9):565-72.
|
|
|
|
|
219.
|
Col NF, Yarzbski J, Gore JM, Alpert JS, Goldberg RJ. Does aspirin consumption affect the presentation or severity of acute myocardial infarction? Arch Intern Med. 1995 Jul 10; 155(13):1386-9.
|
|
|
|
|
220.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1995 Jun 7; 273(21):1662-4.
|
|
|
|
|
221.
|
Sloan MA, Price TR, Petito CK, Randall AM, Solomon RE, Terrin ML, Gore J, Collen D, Kleiman N, Feit F, et al. Clinical features and pathogenesis of intracerebral hemorrhage after rt-PA and heparin therapy for acute myocardial infarction: the Thrombolysis in Myocardial Infarction (TIMI) II Pilot and Randomized Clinical Trial combined experience. Neurology. 1995 Apr; 45(4):649-58.
|
|
|
|
|
222.
|
Becker RC, Charlesworth A, Wilcox RG, Hampton J, Skene A, Gore JM, Topol EJ. Cardiac rupture associated with thrombolytic therapy: impact of time to treatment in the Late Assessment of Thrombolytic Efficacy (LATE) study. J Am Coll Cardiol. 1995 Apr; 25(5):1063-8.
|
|
|
|
|
223.
|
Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Recent trends in hospital mortality of acute myocardial infarction--the Worcester Heart Attack Study. Have improvements been realized for all age groups? Arch Intern Med. 1994 Oct 10; 154(19):2202-8.
|
|
|
|
|
224.
|
Rogers WJ, Bowlby LJ, Chandra NC, French WJ, Gore JM, Lambrew CT, Rubison RM, Tiefenbrunn AJ, Weaver WD. Treatment of myocardial infarction in the United States (1990 to 1993). Observations from the National Registry of Myocardial Infarction. Circulation. 1994 Oct; 90(4):2103-14.
|
|
|
|
|
225.
|
Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J. 1994 Aug; 128(2):255-63.
|
|
|
|
|
226.
|
Pape LA, Love DG, Gore JM. Massive thromboembolic stroke and death after fibrinolytic therapy of St. Jude prosthetic mitral valve thrombosis: documentation by transthoracic Doppler echocardiography. Am Heart J. 1994 Aug; 128(2):406-9.
|
|
|
|
|
227.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1994 Jun 1; 271(21):1660-1.
|
|
|
|
|
228.
|
Becker RC, Terrin M, Ross R, Knatterud GL, Desvigne-Nickens P, Gore JM, Braunwald E. Comparison of clinical outcomes for women and men after acute myocardial infarction. The Thrombolysis in Myocardial Infarction Investigators. Ann Intern Med. 1994 Apr 15; 120(8):638-45.
|
|
|
|
|
229.
|
Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends and factors associated with pulmonary artery catheterization in patients with acute myocardial infarction. Chest. 1994 Apr; 105(4):1003-8.
|
|
|
|
|
230.
|
Chiriboga D, Yarzebski J, Goldberg RJ, Gore JM, Alpert JS. Temporal trends (1975 through 1990) in the incidence and case-fatality rates of primary ventricular fibrillation complicating acute myocardial infarction. A communitywide perspective. Circulation. 1994 Mar; 89(3):998-1003.
|
|
|
|
|
231.
|
White CR, Brock TA, Chang LY, Crapo J, Briscoe P, Ku D, Bradley WA, Gianturco SH, Gore J, Freeman BA, et al. Superoxide and peroxynitrite in atherosclerosis. Proc Natl Acad Sci U S A. 1994 Feb 1; 91(3):1044-8.
|
|
|
|
|
232.
|
Becker RC, Corrao JM, Ball SP, Gore JM. A comparison of heparin strategies after thrombolytic therapy. Am Heart J. 1993 Sep; 126(3 Pt 1):750-2.
|
|
|
|
|
233.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1993 Jul 14; 270(2):190-2.
|
|
|
|
|
234.
|
Becker RC, Caputo R, Ball S, Corrao JM, Baker S, Gore JM. Hemorrhagic potential of combined diltiazem and recombinant tissue-type plasminogen activator administration. Am Heart J. 1993 Jul; 126(1):11-4.
|
|
|
|
|
235.
|
Goldberg RJ, Gorak EJ, Yarzebski J, Hosmer DW, Dalen P, Gore JM, Alpert JS, Dalen JE. A communitywide perspective of sex differences and temporal trends in the incidence and survival rates after acute myocardial infarction and out-of-hospital deaths caused by coronary heart disease. Circulation. 1993 Jun; 87(6):1947-53.
|
|
|
|
|
236.
|
Pagley PR, Yarzebski J, Goldberg R, Chen Z, Chiriboga D, Dalen P, Gurwitz J, Alpert JS, Gore JM. Gender differences in the treatment of patients with acute myocardial infarction. A multihospital, community-based perspective. Arch Intern Med. 1993 Mar 8; 153(5):625-9.
|
|
|
|
|
237.
|
Donahue RP, Goldberg RJ, Chen Z, Gore JM, Alpert JS. The influence of sex and diabetes mellitus on survival following acute myocardial infarction: a community-wide perspective. J Clin Epidemiol. 1993 Mar; 46(3):245-52.
|
|
|
|
|
238.
|
Chiriboga DE, Yarzebski J, Goldberg RJ, Chen Z, Gurwitz J, Gore JM, Alpert JS, Dalen JE. A community-wide perspective of gender differences and temporal trends in the use of diagnostic and revascularization procedures for acute myocardial infarction. Am J Cardiol. 1993 Feb 1; 71(4):268-73.
|
|
|
|
|
239.
|
Gore JM. Patient selection issues in the use of thrombolytic therapy in patients with acute myocardial infarction. Z Kardiol. 1993; 82 Suppl 2:143-6.
|
|
|
|
|
240.
|
Becker RC, Gore JM. The challenge of maintaining coronary arterial patency with intravenous heparin following tissue plasminogen activator administration. Cardiology. 1993; 83(1-2):100-6.
|
|
|
|
|
241.
|
Gurwitz JH, Goldberg RJ, Chen Z, Gore JM, Alpert JS. Beta-blocker therapy in acute myocardial infarction: evidence for underutilization in the elderly. Am J Med. 1992 Dec; 93(6):605-10.
|
|
|
|
|
242.
|
Levine MN, Goldhaber SZ, Califf RM, Gore JM, Hirsh J. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest. 1992 Oct; 102(4 Suppl):364S-373S.
|
|
|
|
|
243.
|
Goldberg RJ, Gurwitz J, Yarzebski J, Landon J, Gore JM, Alpert JS, Dalen PM, Dalen JE. Patient delay and receipt of thrombolytic therapy among patients with acute myocardial infarction from a community-wide perspective. Am J Cardiol. 1992 Aug 15; 70(4):421-5.
|
|
|
|
|
244.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1992 Jul 15; 268(3):338-40.
|
|
|
|
|
245.
|
Goldberg RJ, Zevallos JC, Yarzebski J, Alpert JS, Gore JM, Chen Z, Dalen JE. Prognosis of acute myocardial infarction complicated by complete heart block (the Worcester Heart Attack Study). Am J Cardiol. 1992 May 1; 69(14):1135-41.
|
|
|
|
|
246.
|
Gore JM. Prevention of severe neurologic events in the thrombolytic era. Chest. 1992 Apr; 101(4 Suppl):124S-130S.
|
|
|
|
|
247.
|
Bradley AJ, Gore JM. ST segment depression in right-sided electrocardiographic leads in patients with acute myocardial infarction. Chest. 1992 Feb; 101(2):416-9.
|
|
|
|
|
248.
|
Sloan MA, Gore JM. Ischemic stroke and intracranial hemorrhage following thrombolytic therapy for acute myocardial infarction: a risk-benefit analysis. Am J Cardiol. 1992 Jan 3; 69(2):21A-38A.
|
|
|
|
|
249.
|
Voyce SJ, Ball SP, Gore JM, Shine WJ, Weiner BH. Angiographically documented thrombotic coronary artery occlusion secondary to mild nonpenetrating thoracic trauma. Cathet Cardiovasc Diagn. 1991 Nov; 24(3):179-81.
|
|
|
|
|
250.
|
Gurwitz JH, Osganian V, Goldberg RJ, Chen ZY, Gore JM, Alpert JS. Diagnostic testing in acute myocardial infarction: does patient age influence utilization patterns? The Worcester Heart Attack Study. Am J Epidemiol. 1991 Nov 1; 134(9):948-57.
|
|
|
|
|
251.
|
Goldberg RJ, Gore JM, Alpert JS, Osganian V, de Groot J, Bade J, Chen Z, Frid D, Dalen JE. Cardiogenic shock after acute myocardial infarction. Incidence and mortality from a community-wide perspective, 1975 to 1988. N Engl J Med. 1991 Oct 17; 325(16):1117-22.
|
|
|
|
|
252.
|
Bovill EG, Terrin ML, Stump DC, Berke AD, Frederick M, Collen D, Feit F, Gore JM, Hillis LD, Lambrew CT, et al. Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI), Phase II Trial. Ann Intern Med. 1991 Aug 15; 115(4):256-65.
|
|
|
|
|
253.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1991 Jun 19; 265(23):3105-7.
|
|
|
|
|
254.
|
Gurwitz JH, Goldberg RJ, Gore JM. Coronary thrombolysis for the elderly? JAMA. 1991 Apr 3; 265(13):1720-3.
|
|
|
|
|
255.
|
Rogers WJ, Babb JD, Baim DS, Chesebro JH, Gore JM, Roberts R, Williams DO, Frederick M, Passamani ER, Braunwald E. Selective versus routine predischarge coronary arteriography after therapy with recombinant tissue-type plasminogen activator, heparin and aspirin for acute myocardial infarction. TIMI II Investigators. J Am Coll Cardiol. 1991 Apr; 17(5):1007-16.
|
|
|
|
|
256.
|
Becker RC, Gore JM. Adjuvant antiplatelet strategies in coronary thrombolysis. Circulation. 1991 Mar; 83(3):1115-7.
|
|
|
|
|
257.
|
Becker RC, Gore JM. Cardiovascular therapies in the 1990s. An overview. Drugs. 1991 Mar; 41(3):345-57.
|
|
|
|
|
258.
|
Voyce SJ, Goldberg RJ, Gore JM. Evaluation of right-heart catheterization: where do we go from here? J Intensive Care Med. 1991 Mar-Apr; 6(2):98-100.
|
|
|
|
|
259.
|
Ockene IS, Miner J, Shannon TA, Gore JM, Weiner BH, Ball SP. The consent process in the Thrombolysis in Myocardial Infarction (TIMI--phase I) trial. Clin Res. 1991 Feb; 39(1):13-7.
|
|
|
|
|
260.
|
Gore JM, Sloan M, Price TR, Randall AM, Bovill E, Collen D, Forman S, Knatterud GL, Sopko G, Terrin ML. Intracerebral hemorrhage, cerebral infarction, and subdural hematoma after acute myocardial infarction and thrombolytic therapy in the Thrombolysis in Myocardial Infarction Study. Thrombolysis in Myocardial Infarction, Phase II, pilot and clinical trial. Circulation. 1991 Feb; 83(2):448-59.
|
|
|
|
|
261.
|
Becker RC, Gore JM. Adjunctive use of beta-adrenergic blockers, calcium antagonists and other therapies in coronary thrombolysis. Am J Cardiol. 1991 Jan 25; 67(3):25A-31A.
|
|
|
|
|
262.
|
Becker RC, Corrao JM, Harrington R, Ball SP, Gore JM. Recombinant tissue-type plasminogen activator: current concepts and guidelines for clinical use in acute myocardial infarction. Part I. Am Heart J. 1991 Jan; 121(1 Pt 1):220-44.
|
|
|
|
|
263.
|
Hendel RC, Gore JM, Alpert JS, Leppo JA. Prognosis following interventional therapy for acute myocardial infarction: utility of dipyridamole thallium scintigraphy. Cardiology. 1991; 79(1):73-80.
|
|
|
|
|
264.
|
Spangler DE, Rogers WJ, Gore JM, Griffith M, Maske LE, Morgan TE, Corrao J. Early tPA treatment and aeromedical transport of patients with acute myocardial infarction. J Interv Cardiol. 1991; 4(2):81-9.
|
|
|
|
|
265.
|
Ball SP, Corrao JM, Goldberg RJ, Chen Z, Gore JM. Thrombolytic therapy and the nursing profession. Results of a statewide survey. Crit Care Nurs Clin North Am. 1990 Dec; 2(4):643-50.
|
|
|
|
|
266.
|
Michelson AD, Gore JM, Rybak ME, Cola CA, Barnard MR. Effect of in vivo infusion of recombinant tissue-type plasminogen activator on platelet glycoprotein Ib. Thromb Res. 1990 Dec 1; 60(5):421-4.
|
|
|
|
|
267.
|
Becker RC, Corrao JM, Bovill EG, Gore JM, Baker SP, Miller ML, Lucas FV, Alpert JA. Intravenous nitroglycerin-induced heparin resistance: a qualitative antithrombin III abnormality. Am Heart J. 1990 Jun; 119(6):1254-61.
|
|
|
|
|
268.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1990 May 16; 263(19):2629-31.
|
|
|
|
|
269.
|
Goldberg RJ, Seeley D, Becker RC, Brady P, Chen ZY, Osganian V, Gore JM, Alpert JS, Dalen JE. Impact of atrial fibrillation on the in-hospital and long-term survival of patients with acute myocardial infarction: a community-wide perspective. Am Heart J. 1990 May; 119(5):996-1001.
|
|
|
|
|
270.
|
Rogers WJ, Baim DS, Gore JM, Brown BG, Roberts R, Williams DO, Chesebro JH, Babb JD, Sheehan FH, Wackers FJ, et al. Comparison of immediate invasive, delayed invasive, and conservative strategies after tissue-type plasminogen activator. Results of the Thrombolysis in Myocardial Infarction (TIMI) Phase II-A trial. Circulation. 1990 May; 81(5):1457-76.
|
|
|
|
|
271.
|
Becker RC, Gore JM. Tissue plasminogen activator and intracranial hemorrhage. Ann Intern Med. 1990 Apr 15; 112(8):630.
|
|
|
|
|
272.
|
Gore JM, Thompson MJ, Becker RC. Rapid resolution of acute cor pulmonale with recombinant tissue plasminogen activator. Chest. 1989 Oct; 96(4):939-41.
|
|
|
|
|
273.
|
Zahler R, Chelmow D, Gore J, Wilkens K, Pope C, Sostman HD, Meese R, Negro-Vilar R, Herfkens RJ, Wackers FJ, et al. Heterogeneous signal intensity in magnetic resonance images of hypertrophied left ventricular myocardium. Magn Reson Imaging. 1989 Sep-Oct; 7(5):517-28.
|
|
|
|
|
274.
|
Dahlberg S, Burke M, Gore JM. Bilateral brachial artery emboli presenting as aortic dissection. Arch Intern Med. 1989 Jun; 149(6):1419-20.
|
|
|
|
|
275.
|
Gore JM, Dalen JE. Cardiovascular disease. JAMA. 1989 May 19; 261(19):2829-31.
|
|
|
|
|
276.
|
Chiles C, Hawrot E, Gore J, Byck R. Magnetic field modulation of receptor binding. Magn Reson Med. 1989 May; 10(2):241-5.
|
|
|
|
|
277.
|
McCarthy S, Scott G, Majumdar S, Shapiro B, Thompson S, Lange R, Gore J. Uterine junctional zone: MR study of water content and relaxation properties. Radiology. 1989 Apr; 171(1):241-3.
|
|
|
|
|
278.
|
Goldberg RJ, Gore JM, Gurwitz JH, Alpert JS, Brady P, Strohsnitter W, Chen ZY, Dalen JE. The impact of age on the incidence and prognosis of initial acute myocardial infarction: the Worcester Heart Attack Study. Am Heart J. 1989 Mar; 117(3):543-9.
|
|
|
|
|
279.
|
Gore JM, Corrao JM, Goldberg RJ, Ball SP, Weiner BH, Aghababian RV, Dalen JE. Feasibility and safety of emergency interhospital transport of patients during early hours of acute myocardial infarction. Arch Intern Med. 1989 Feb; 149(2):353-5.
|
|
|
|
|
280.
|
Becker RC, Gore JM, Alpert JS. Postinfarction unstable angina. Pathophysiologic basis for current treatment modalities. Cardiology. 1989; 76(2):144-57.
|
|
|
|
|
281.
|
Held AC, Cole PL, Lipton B, Gore JM, Antman EM, Hockman JS, Corrao J, Goldberg RJ, Alpert JS. Rupture of the interventricular septum complicating acute myocardial infarction: a multicenter analysis of clinical findings and outcome. Am Heart J. 1988 Nov; 116(5 Pt 1):1330-6.
|
|
|
|
|
282.
|
Gore JM, Ball SP, Corrao JM, Goldberg RJ. Arrhythmias in the assessment of coronary artery reperfusion following thrombolytic therapy. Chest. 1988 Oct; 94(4):727-30.
|
|
|
|
|
283.
|
Stone PH, Ware JH, DeWood MA, Gore JM, Eich RH, Pietro DA, Parisi AF, Nesto RW, Boden WE, Sharma SC, et al. The efficacy of the addition of nifedipine in patients with mixed angina compared to patients with classic exertional angina: a multicenter, randomized, double-blind, placebo-controlled clinical trial. Am Heart J. 1988 Oct; 116(4):961-71.
|
|
|
|
|
284.
|
Dalen JE, Gore JM, Braunwald E, Borer J, Goldberg RJ, Passamani ER, Forman S, Knatterud G. Six- and twelve-month follow-up of the phase I Thrombolysis in Myocardial Infarction (TIMI) trial. Am J Cardiol. 1988 Aug 1; 62(4):179-85.
|
|
|
|
|
285.
|
Held AC, Gore JM, Paraskos J, Pape LA, Ball SP, Corrao JM, Alpert JS. Impact of thrombolytic therapy on left ventricular mural thrombi in acute myocardial infarction. Am J Cardiol. 1988 Aug 1; 62(4):310-1.
|
|
|
|
|
286.
|
Gore JM, Dalen JE. Pulmonary artery catheters. Chest. 1988 May; 93(5):1115.
|
|
|
|
|
287.
|
Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Incidence and case fatality rates of acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Am Heart J. 1988 Apr; 115(4):761-7.
|
|
|
|
|
288.
|
Gore JM, Becker RC. Management of post-infarction angina. Cardiol Clin. 1988 Feb; 6(1):165-72.
|
|
|
|
|
289.
|
Voyce SJ, Goldfine HL, Gore JM. Severe metabolic and respiratory alkalosis associated with the treatment of congestive heart failure. Arch Intern Med. 1987 Dec; 147(12):2211-2.
|
|
|
|
|
290.
|
Gore JM, Goldberg RJ, Spodick DH, Alpert JS, Dalen JE. A community-wide assessment of the use of pulmonary artery catheters in patients with acute myocardial infarction. Chest. 1987 Oct; 92(4):721-7.
|
|
|
|
|
291.
|
Gore JM, Goldberg RJ, Alpert JS, Dalen JE. The increased use of diagnostic procedures in patients with acute myocardial infarction. A community-wide perspective. Arch Intern Med. 1987 Oct; 147(10):1729-32.
|
|
|
|
|
292.
|
Goldberg RJ, Gore JM, Dalen JE. Current practice patterns in the management of acute myocardial infarction. Survey of the American College of Chest Physicians. Chest. 1987 Sep; 92(3):550-4.
|
|
|
|
|
293.
|
Gore JM, Roberts R, Ball SP, Montero A, Goldberg RJ, Dalen JE. Peak creatine kinase as a measure of effectiveness of thrombolytic therapy in acute myocardial infarction. Am J Cardiol. 1987 Jun 1; 59(15):1234-8.
|
|
|
|
|
294.
|
Sheehan FH, Braunwald E, Canner P, Dodge HT, Gore J, Van Natta P, Passamani ER, Williams DO, Zaret B. The effect of intravenous thrombolytic therapy on left ventricular function: a report on tissue-type plasminogen activator and streptokinase from the Thrombolysis in Myocardial Infarction (TIMI Phase I) trial. Circulation. 1987 Apr; 75(4):817-29.
|
|
|
|
|
295.
|
Voyce SJ, Gore JM, Murphy KR, VanderSalm TJ, Dalen JE. Accurate patient diagnosis of acute porcine valve failure. Arch Intern Med. 1987 Mar; 147(3):585-6.
|
|
|
|
|
296.
|
Goldberg RJ, Gore JM, Haffajee CI, Alpert JS, Dalen JE. Outcome after cardiac arrest during acute myocardial infarction. Am J Cardiol. 1987 Feb 1; 59(4):251-5.
|
|
|
|
|
297.
|
Goldberg RJ, Seneff M, Gore JM, Anderson FA, Greene HL, Wheeler HB, Dalen JE. Occult malignant neoplasm in patients with deep venous thrombosis. Arch Intern Med. 1987 Feb; 147(2):251-3.
|
|
|
|
|
298.
|
Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Non-Q wave myocardial infarction: recent changes in occurrence and prognosis--a community-wide perspective. Am Heart J. 1987 Feb; 113(2 Pt 1):273-9.
|
|
|
|
|
299.
|
Goldberg RJ, Gore JM, Zive M, Brady P, Klaiber E, Broverman D, Ockene IS, Dalen JE. Serum estradiol and coronary artery disease. Am J Med. 1987 Jan; 82(1):1-4.
|
|
|
|
|
300.
|
Brady PM, Zive MA, Goldberg RJ, Gore JM, Dalen JE. A new wrinkle to the earlobe crease. Arch Intern Med. 1987 Jan; 147(1):65-6.
|
|
|
|
|
301.
|
Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Therapeutic trends in the management of patients with acute myocardial infarction (1975-1984): the Worcester Heart Attack Study. Clin Cardiol. 1987 Jan; 10(1):3-8.
|
|
|
|
|
302.
|
Gore JM, Weiner BH, Benotti JR, Sloan KM, Okike ON, Cuénoud HF, Gaca JM, Alpert JS, Dalen JE. Preliminary experience with synchronized coronary sinus retroperfusion in humans. Circulation. 1986 Aug; 74(2):381-8.
|
|
|
|
|
303.
|
Goldberg RJ, Gore JM, Alpert JS, Dalen JE. Recent changes in attack and survival rates of acute myocardial infarction (1975 through 1981). The Worcester Heart Attack Study. JAMA. 1986 May 23-30; 255(20):2774-9.
|
|
|
|
|
304.
|
Pope C, Gore J, Sostman D, Lange R, Riely C. Diffuse fatty infiltration of the liver by magnetic resonance. Magn Reson Imaging. 1986; 4(3):267-70.
|
|
|
|
|
305.
|
Goldberg RJ, Gore JM, Dalen JE, Alpert JS. Long-term anticoagulant therapy after acute myocardial infarction. Am Heart J. 1985 Mar; 109(3 Pt 1):616-22.
|
|
|
|
|
306.
|
Goldberg RJ, DeCosimo D, St Louis P, Gore JM, Ockene JK, Dalen JE. Physicians' attitudes and practices toward CPR training in family members of patients with coronary heart disease. Am J Public Health. 1985 Mar; 75(3):281-3.
|
|
|
|
|
307.
|
Hill JA, O'Brien JT, Alpert JS, Gore JM, Zusman RM, Christensen D, Boucher CA, Vetrovec G, Borer JS, Friedman C, et al. Effect of bepridil in patients with chronic stable angina: results of a multicenter trial. Circulation. 1985 Jan; 71(1):98-103.
|
|
|
|
|
308.
|
Goldberg RJ, Gore JM, Dalen JE. The role of anticoagulant therapy in acute myocardial infarction. Am Heart J. 1984 Nov; 108(5):1387-93.
|
|
|
|
|
309.
|
Gore JM, Sloan K. Use of continuous monitoring of mixed venous saturation in the coronary care unit. Chest. 1984 Nov; 86(5):757-61.
|
|
|
|
|
310.
|
Gore JM, Haffajee CI, Alpert JS. Interaction of amiodarone and diphenylhydantoin. Am J Cardiol. 1984 Nov 1; 54(8):1145.
|
|
|
|
|
311.
|
Malloy PC, Gore JM, Rippe JM, Paraskos JA, Benotti JR, Ockene IS, Alpert JS, Dalen JE. Transient right atrial thrombus resulting in pulmonary embolism detected by two-dimensional echocardiography. Am Heart J. 1984 Oct; 108(4 Pt 1):1047-9.
|
|
|
|
|
312.
|
Gore JM, Goldberg RJ, Matsumoto AS, Castelli WP, McNamara PM, Dalen JE. Validity of serum total cholesterol level obtained within 24 hours of acute myocardial infarction. Am J Cardiol. 1984 Oct 1; 54(7):722-5.
|
|
|
|
|
313.
|
Goldberg RJ, Gore JM, Love DG, Ockene JK, Dalen JE. Layperson CPR--are we training the right people? Ann Emerg Med. 1984 Sep; 13(9 Pt 1):701-4.
|
|
|
|
|
314.
|
Dalen JE, Goldberg RJ, Gore JM, Struckus J. Therapeutic interventions in acute myocardial infarction. Survey of the ACCP Section on Clinical Cardiology. Chest. 1984 Aug; 86(2):257-62.
|
|
|
|
|
315.
|
Love JC, Haffajee CI, Gore JM, Alpert JS. Reversibility of hypotension and shock by atrial or atrioventricular sequential pacing in patients with right ventricular infarction. Am Heart J. 1984 Jul; 108(1):5-13.
|
|
|
|
|
316.
|
Gore JM, Matsumoto AH, Layden JJ, Haffajee CI, Love JC, Alpert JS, Dalen JE. Superior vena cava syndrome. Its association with indwelling balloon-tipped pulmonary artery catheters. Arch Intern Med. 1984 Mar; 144(3):506-8.
|
|
|
|
|
317.
|
Gore JM, Haffajee CI, Love JC, Dalen JE. Isolated right ventricular tamponade after pericarditis from acute myocardial infarction. Am J Cardiol. 1984 Jan 15; 53(2):372-3.
|
|
|
|
|
318.
|
DiBianco R, Alpert J, Katz RJ, Spann J, Chesler E, Ferri DP, Larca LJ, Costello RB, Gore JM, Eisenman MJ. Bepridil for chronic stable angina pectoris: results of a prospective multicenter, placebo-controlled, dose-ranging study in 77 patients. Am J Cardiol. 1984 Jan 1; 53(1):35-41.
|
|
|
|
|
319.
|
Gore JM, Haffajee CI, Goldberg RJ, Ostroff M, Shustak CL, Cahill NM, Howe JP, Dalen JE. Evaluation of an emergency cardiac transport system. Ann Emerg Med. 1983 Nov; 12(11):675-8.
|
|
|
|
|
320.
|
Goldberg RJ, Gore JM. Hospital care for acute myocardial infarction. Circulation. 1982 Oct; 66(4):903.
|
|
|
|
|
321.
|
Goldberg RJ, Kennedy HL, Gore JM. Absence of secular changes in the prognosis of patients with an initial myocardial infarction. Clin Cardiol. 1982 Sep; 5(9):469-75.
|
|
|
|
|
322.
|
Gore JM, Haffajee CI, Collins JJ, Dalen JE. Acute spontaneous failure of a porcine aortic valve. Arch Intern Med. 1982 Aug; 142(8):1553-4.
|
|
|
|
|
323.
|
Gore JM, Appelbaum JS, Greene HL, Dexter L, Dalen JE. Occult cancer in patients with acute pulmonary embolism. Ann Intern Med. 1982 May; 96(5):556-60.
|
|
|
|
